Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2431 AL 2445

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review

Tsunemi T, Oyama G, Saiki S, Hatano T, Fukae J, Shimo Y, Hattori N.

Mov Disord. 2021 Aug;36(8):1759-1771. doi: 10.1002/mds.28595. Epub 2021 Apr 25.

Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study

Fasano A, Gurevich T, Jech R, Kovács N, Svenningsson P, Szász J, Parra JC, Bergmann L, Johnson A, Sanchez-Soliño O, Tang Z, Vela-Desojo L.

Mov Disord. 2021 Aug;36(8):1853-1862. doi: 10.1002/mds.28596. Epub 2021 Apr 28.

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression

Putri C, Hariyanto TI, Hananto JE, Christian K, Situmeang RFV, Kurniawan A.

Parkinsonism Relat Disord. 2021 Jun;87:155-161. doi: 10.1016/j.parkreldis.2021.04.019. Epub 2021 Apr 24.

Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases

Koss DJ, Campesan S, Giorgini F, Outeiro TF.

Mov Disord. 2021 Aug;36(8):1744-1758. doi: 10.1002/mds.28605. Epub 2021 May 3.

Dopamine Receptors in Parkinson's Disease: A Meta-Analysis of Imaging Studies

Kaasinen V, Vahlberg T, Stoessl AJ, Strafella AP, Antonini A.

Mov Disord. 2021 Aug;36(8):1781-1791. doi: 10.1002/mds.28632. Epub 2021 May 6.

Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease

McIntosh E, Kent S, Gray A, Clarke CE, Williams A, Jenkinson C, Ives N, Patel S, Rick C, Wheatley K, Gray R; PD MED Collaborative Group.

Mov Disord. 2021 Sep;36(9):2136-2143. doi: 10.1002/mds.28623. Epub 2021 May 7.

Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease

Barbuti PA, Barker RA, Brundin P, Przedborski S, Papa SM, Kalia LV, Mochizuki H; MDS Scientific Issues Committee.

Mov Disord. 2021 Aug;36(8):1772-1780. doi: 10.1002/mds.28628. Epub 2021 May 8.

Focused Ultrasound Thalamotomy for Tremor-dominant Parkinson's Disease: A Prospective 1-year Follow-up Study

Yamamoto K, Ito H, Fukutake S, Odo T, Kamei T, Yamaguchi T, Taira T.

Neurol Med Chir (Tokyo). 2021 Jul 15;61(7):414-421. doi: 10.2176/nmc.oa.2020-0370. Epub 2021 May 8.

Salivary caffeine in Parkinson's disease

Leodori G, De Bartolo MI, Belvisi D, Ciogli A, Fabbrini A, Costanzo M, Manetto S, Conte A, Villani C, Fabbrini G, Berardelli A.

Sci Rep. 2021 May 10;11(1):9823. doi: 10.1038/s41598-021-89168-6.

Effect of Exercise on Parkinson's Disease Tremor: A Meta-analysis Study

Farashi S, Kiani L, Bashirian S.

Tremor Other Hyperkinet Mov (N Y). 2021 Apr 27;11:15. doi: 10.5334/tohm.599.

Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease

Marras C, Mills KA, Eberly S, Oakes D, Chou KL, Halverson M, Parashos SA, Tarolli CG, Lai JS, Nowinsky CJ, Suchowersky O, Farbman ES, Shulman LM, Simuni T.

Mov Disord. 2021 Aug;36(8):1979-1983. doi: 10.1002/mds.28641. Epub 2021 May 13.

Sleep Disorders in Parkinson Disease

Stefani A, Högl B.

Sleep Med Clin. 2021 Jun;16(2):323-334. doi: 10.1016/j.jsmc.2021.03.001. Epub 2021 Apr 15.

Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease

Olson KE, Namminga KL, Lu Y, Schwab AD, Thurston MJ, Abdelmoaty MM, Kumar V, Wojtkiewicz M, Obaro H, Santamaria P, Mosley RL, Gendelman HE.

EBioMedicine. 2021 May;67:103380. doi: 10.1016/j.ebiom.2021.103380. Epub 2021 May 14.

Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis

Mei YL, Yang J, Wu ZR, Yang Y, Xu YM.

Parkinsons Dis. 2021 Apr 30;2021:8891874. doi: 10.1155/2021/8891874. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias